Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access


IJHSR. 2015; 5(11): 198-204

A Comparative Study on Management of Diabetes Mellitus Relation to Dipeptidyl Peptidase-4 Inhibitors.

Sarika Goud Bommena, Kolla Navya Likitha, Venkateswarlu Konuru, Preeti Vemula, Venu Madhav Neerati.

Background: The incidence of Diabetes Mellitus has increased dramatically in recent decades. Di Peptidyl Peptidase 4 inhibitors (DPP-4) have their role in glycemic control. An impaired ‘incretin effect’, occurs in patients with type 2 Diabetes Mellitus in response to glucose intake.
Objectives: The main objective of the study is to compare therapeutic outcomes and adverse drug reactions among commonly prescribed anti diabetic drug combinations in adults with type 2 diabetes mellitus.
Methodology: A retrospective and prospective study experimental study was carried out for a period of one year at care diabetes centre, Warangal, Telangana.
Results: FBS and PLBS were found to be significantly lower in DPP group when compared with SU and TZ. Adverse events such as itching, abdominal pain, constipation and weight loss are more in DPP when compared with other groups. Data from this study indicated thatDPP-4 inhibitors are superior to sulfonylureas (SU) and thiazolidinediones (TZ) when used in combination with metformin (B) in glycemic control.
Conclusion: DPP inhibitors provide an effective therapeutic option for individuals with Type 2 Diabetes along with obesity.

Key words: Diabetes Mellitus (DM) , Dipeptidyl peptidase 4 inhibitors (DPP), Sulfonylureas (SU), Thiazolidinediones (TZ) , Fasting blood sugar (FBS), Post prandial blood sugar (PLBS), Adverse events (AE).

Share this Article

American Journal of Research in Medical Sciences


ScopeMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About ScopeMed
License Information
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.
Scopemed Buttons